Novartis - Statistics & Facts

In 2017, Swiss-based Novartis was the second largest pharmaceutical company worldwide based on revenue from prescription drugs. In 2018, Novartis made nearly 52 billion U.S. dollars of revenue in total, a slight increase compared to the previous year. The company made some significant restructuring measures during 2015 and also had some revenue losses through the patent loss of top drug Gleevec.

Today, Novartis is divided into three segments: Pharmaceuticals (now called Innovative Medicines), Alcon, and Sandoz. The Pharmaceuticals segment is responsible for the largest part of the total revenue – around 35 billion U.S. dollars. From a regional point of view, Novartis generates the overwhelming part of its revenue in the United States and in Europe. In 2018, about 19.1 billion U.S. dollars were generated in Europe and some 17.6 billion dollars in the United States. Among Novartis’ top products are immunomodulating drug Gilenya and ophthalmic drug Lucentis. It is estimated that Novartis reaches over 800 million people worldwide through its products.

More than nine billion U.S. dollars – almost 18 percent of Novartis’ total revenue – was spent on research and development in 2018. R&D is a major issue for the top pharmaceutical companies because patent expiration can lead to massive revenue losses. Thus, only new medicines with at least a few years of exclusivity can ensure progress and profit. At Novartis, such growth products made up more than one third of its total revenues.

Interesting statistics

In the following 5 chapters, you will quickly find the 18 most important statistics relating to "Novartis".

Novartis

Dossier on the topic

All important statistics are prepared by our experts – available for direct download as PPT & PDF!
TOP SELLER

Important key figures

The most important key figures provide you with a compact summary of the topic of "Novartis" and take you straight to the corresponding statistics.

Company Overview

Research and Development

More interesting topics from the industry "Pharmaceutical Products & Market"

Related topics

Any more questions?

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Get in touch with us quickly and easily.
We are happy to help!

Do you still have questions?

Feel free to contact us anytime using our contact form or visit our FAQ page.